Editorial: How does the risk of hepatocellular carcinoma change over time in patients with a hepatitis C cure?

Aliment Pharmacol Ther. 2024 Feb;59(3):417-418. doi: 10.1111/apt.17818.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Carcinoma, Hepatocellular*
  • Hepacivirus
  • Hepatitis C* / complications
  • Hepatitis C* / drug therapy
  • Humans
  • Liver Neoplasms*